Kevin Hibbert
Analyst · TD Securities. Your line is open
Thanks, Peter, and good morning, everyone. I’ll start on Slide 7 with a look at our earnings summary. As you know, 2017 was a year of significant transition and change for our company, which led to a fair bit of noise in our 2017 financial results. With this in mind, over the next four quarters, I will be separately highlighting the results of our core go-forward businesses to ensure you have a more meaningful analysis of our comparative results. Adjusted base EBITDA in the quarter was $10 million, as Peter mentioned earlier. That was down $5.9 million or 37% from the prior period. Excluding the impact of last year’s sale transaction, loan loss provision reversal and related catch-up interest, adjusted base EBITDA was actually up $3.8 million or 61%. The increase in earnings on a normalized basis from our core remaining businesses was due to higher net fees generated on the newly acquired CFCL assets. Looking at our revenue performance, details of which can be found on Slide 13, total net revenues for the quarter were $27.2 million, an increase of $300,000 or 1% from Q1 2017. Key revenue items worth noting include net fees, interest income and net commissions. Net fees for the quarter were $14.6 million, a decrease of $2.2 million or 13% from Q1 2017. Excluding net fees that were earned on the diversified assets sold as part of last year’s sale transaction, net fees generated by our remaining core businesses were actually up $4.8 million or 49% from this time last year. The increase on a normalized basis was due to management fee generation on the newly acquired CFCL assets. However, we also experienced increased fee generation from our lending LPs as we continue to deploy committed capital in this area. Interest income for the quarter was $2.7 million, a decrease of $3.1 million from Q1 2017. Excluding last year’s impact of catch-up interest recorded on a previously impaired loan, interest income was down only $500,000 as a result of the ongoing runoffs of our on-balance sheet loan book in substitution for fee-earning AUM in our lending LPs. Net commissions for the quarter were $5.2 million, up $200,000 or 4%, largely unchanged from the prior period. Total expenses, details of which can be found on Slide 14, were $16.4 million, a decrease of $500,000 or 3% from Q1 2017. Key expense items worth noting include compensation and SG&A. Compensation, excluding commissions and performance fee payouts, which are presented net of their related revenues in our MD&A and excluding severance accruals, which are nonrecurring, was $9.5 million, a decrease of $3 million or 24% from Q1 2017. The decrease was due to a combination of lower headcount and lower incentive accruals as a result of last year’s sale transaction. SG&A was $4.7 million, a decrease of $1.9 million or 29% from the prior period. This was largely due to lower marketing and sales, professional fees, technology and fund operating expenses, again, as a result of last year’s sale transaction. On Slide 8, you’ll see a summary of our AUM. And for a greater detail into our individual AUM components, you can refer to Slide 12. As of March 31, AUM was $11.6 billion, up $4.3 billion or 58% from December 31, 2017. The increase was due to the successful acquisition of CFCL, net of previously anticipated redemptions. We also benefited from improved precious metals prices in our Physical Trusts during the quarter. Finally, a look at Slide 9 for our investable capital. The CFCL transaction closed in January, and the $105 million of upfront cash required on closing was funded entirely through the balance sheet and has been immediately accretive to EBITDA since its on-boarding. Our remaining investable capital will continue to be deployed in a highly disciplined manner so as to ensure maximum shareholder benefit. I’ll now pass it back to Peter for some final thoughts.